Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Early intervention and patient education are crucial for managing alopecia areata.

High ornithine decarboxylase levels may lead to hair loss and cancer by increasing CK2 activity in the nucleus.

Hordenine may help hair grow by activating a specific cell growth pathway.

Biotin may help treat inflammatory bowel disease by reducing inflammation and improving gut health.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Targeting specific T cells may help treat alopecia areata.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Researchers developed a 3D skin model with its own immune and blood vessel cells to better understand skin health and disease.

Nivolumab can cause hair loss as a rare side effect.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

A lotion with 5% minoxidil boosts the immune response in guinea pigs.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Blocking LFA-1 prevents hair loss in mice.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Chemotherapy drugs can cause abnormal growth and changes in healthy skin and gland cells.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

CD146 + mesenchymal stem cells are more effective for treating premature ovarian failure.

MSCs and their exosomes may speed up skin wound healing but need more research for consistent use.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Abnormal keratin expression in mice causes severe oral issues, affecting feeding.

Substance P may play a role in the inflammation seen in keratosis follicularis spinulosa decalvans.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.